Grace Therapeutics, Inc.

GRCE·NasdaqCM
Compare
2.0200−0.0600 (−2.88%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD
After hours1.9800−0.0400 (−1.98%)Oct 12, 4:31 PM EDT

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close2.0800
Open2.0200
Day range1.98002.0400
52-week range1.79005.1800
Off day high−0.98%
Off 52-week high−61.00%
Volume49.55K
Avg. volume (3M)168.08K
Market cap42.49M
EPS (TTM)-1.17
Forward P/E-4.50
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding21.04M
Short interest—
Earnings dateJun 20, 2025 (est.)
Analyst target—
Profit margin—

Against its peers

Compare in full ›
GRCE HRTX TENX TNXP ATOS ALGS
Market cap 42.49M 78.90M 68.49M 113.88M 23.84M 34.53M
P/E (TTM) — — — — — —
Forward P/E -4.5 -3.8 -1.2 -0.8 -0.7 -1.1
Price/book 0.7 13.4 0.8 0.5 0.9 1.1
Dividend yield — — — — — —
1-year change −30.43% −68.46% −74.76% −63.61% −84.53% −42.75%
Today −2.88% +2.34% −2.14% −9.04% −2.10% +3.56%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All GRCE news ›

No recent coverage in the 4Search index.

From articles in the 4Search news index.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.